tiprankstipranks
Trending News
More News >
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market

Spyre Therapeutics (SYRE) Balance Sheet

Compare
488 Followers

Spyre Therapeutics Balance Sheet

Spyre Therapeutics's total assets for Q3 2025 were $504.60M, a decrease of -6.35% from the previous quarter. SYRE total liabilities were $49.50M for the fiscal quarter, a -40.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 608.48M$ 341.86M$ 71.14M$ 109.93M$ 161.62M
Total Liabilities
$ 90.68M$ 157.84M$ 20.84M$ 25.98M$ 21.79M
Total Equity Gross Minority
$ 517.80M$ 184.02M$ 50.30M$ 83.94M$ 139.83M
Other Metrics
Currency in USD

Spyre Therapeutics Debt to Assets